SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9815	Companies
196919	Keywords
127969	Articles
104716	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 07/22/2025 at 07:30, 6 months 14 days ago

Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de vaccins respiratoires
Sanofi acquiert Vicebio pour enrichir son pipeline de vaccins respiratoires avec la technologie 'Molecular Clamp'. Accord d'1,15 milliards de dollars. Acquisition renforce l'innovation et le développement de vaccins

Acquisition Sanofi Vicebio Vaccins Respiratoires Molecular Clamp
BRIEF

published on 07/18/2025 at 07:05, 6 months 18 days ago

Sanofi finalise l'acquisition de Blueprint Medicines

Acquisition Sanofi Médicaments Blueprint Mastocytose Systémique Ayvakit
BRIEF

published on 07/18/2025 at 07:05, 6 months 18 days ago

Sanofi Completes Acquisition of Blueprint Medicines

Acquisition Sanofi Blueprint Medicines Systemic Mastocytosis Ayvakit
PRESS RELEASE

published on 07/18/2025 at 07:00, 6 months 18 days ago

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines
Sanofi finalise l’acquisition de Blueprint Medicines, ajoutant des médicaments sur le marché, un pipeline prometteur et l'expertise en mastocytose systémique. Acquisition bénéfique pour Sanofi, sans impact significatif sur les prévisions financières 2025

Acquisition Médicaments Sanofi Blueprint Medicines Mastocytose Systémique
PRESS RELEASE

published on 07/18/2025 at 07:00, 6 months 18 days ago

Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline

Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt
BRIEF

published on 07/16/2025 at 07:05, 6 months 20 days ago

Sanofi : Désignation "fast track" pour le SAR446597 aux États-Unis

FDA Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track
BRIEF

published on 07/16/2025 at 07:05, 6 months 20 days ago

Sanofi: Fast track designation for SAR446597 in the United States

FDA Gene Therapy Sanofi Macular Degeneration Fast Track
PRESS RELEASE

published on 07/16/2025 at 07:00, 6 months 20 days ago

Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge
Sanofi obtient la désignation 'fast track' pour le traitement innovant de l'atrophie géographique liée à la dégénérescence maculaire. Le SAR446597 vise à inhiber des voies clés du complément pour une meilleure efficacité

Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track Atrophie Géographique
PRESS RELEASE

published on 07/16/2025 at 07:00, 6 months 20 days ago

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy

Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE

published on 07/15/2025 at 18:30, 6 months 21 days ago

Sanofi: Disclosure of trading in own shares

Accesswire

Published on 02/06/2026 at 03:50, 2 hours 25 minutes ago

High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 3 hours 30 minutes ago

High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 5 hours 18 minutes ago

Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 6 hours 15 minutes ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 7 hours ago

Amarc Further Expands Its Toodoggone Technical Team

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 06:05, 9 minutes ago

Driven by Chairman Junhyuk Bang's Visionary Leadership, Coway Announces Financial Results for Q4 and FY2025
Published on 02/06/2026 at 05:50, 24 minutes ago

CGTN: Xi Jinping's same-day calls with Putin and Trump underscore China's role in global stability
Published on 02/05/2026 at 19:27, 10 hours 47 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 11 hours 28 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 12 hours 5 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares

Les Echos

Published on 02/05/2026 at 19:24, 10 hours 50 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 10 hours 50 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 11 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 11 hours ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 11 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE